Medical Mythbusting Commentary for November 13, 2023
Source:
Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds
Reference:
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Medical Mythbusting Commentary for November 13, 2023
Source:
Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds
Reference:
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes